Barbora Hosikova

Dr. Barbora Hosikova


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2023 in Journal of Xenobiotics
Verified
Journal Article
Open access
PDF file
JCJan Chrz
Jan Chrz
MDMarketa DVORAKOVA
Marketa DVORAKOVA
KKKristina Kejlová
Kristina Kejlová
DODanuše Očadlíková
Danuše Očadlíková
LSLada Svobodova
Lada Svobodova
HKHana Kolarova
Hana Kolarova
Triclosan and Triclocarban, preservatives widely used in cosmetics and other consumer products, underwent evaluation using a battery of new-approach methodologies in vitro (NAMs). Specifically, the Microplate Ames Test (MPF™ Test, Xenometrix, Allschwil, Switzerland) was employed to assess mutagenicity, the Comet assay in vitro on the HaCat cell line and the Mammalian Chromosome Aberration Test were utilized to evaluate genotoxicity, and the XenoScreen® YES/YAS assay was applied to investigate endocrine disruption. The chemicals did not exhibit any positive responses for mutagenicity. However, the mammalian chromosome aberration test identified both chemicals as being positive for genotoxicity at 10 µg/mL. In the Comet assay, the percentage of DNA in the tail significantly increased in a concentration-dependent manner (at 5 and 10 µg/mL for Triclosan, at 2.5, 5, and 10 µg/mL for Triclocarban). The positive response depended on the increasing concentration and the duration of exposure. Triclosan, but not Triclocarban in any of the endocrine assays performed, indicated a potential for endocrine activity in the anti-estrogenic and anti-androgenic assays. The positive in vitro results detected were obtained for concentrations relevant to final products. The alarming findings obtained with the use of new-approach methodologies (NAMs) justify the current precautionary regulatory approach, limiting the use of these preservatives.

Verified
Journal Article
Open access
PDF file
JHJakub Hosik
Jakub Hosik
BHBarbora Hosikova
Barbora Hosikova
SBSvatopluk Binder
Svatopluk Binder
RLRene Lenobel
Rene Lenobel
MKMarketa Kolarikova
Marketa Kolarikova
HKHana Kolarova
Hana Kolarova
This work presents results on the efficiency of newly designed zinc phthalocyanine-mediated photodynamic therapy of both tumoral and nontumoral cell models using the MTT assay. Further detailed examinations of mechanistic and cell biological effects were focused on the HELA cervical cancer cell model. Here, ROS production, changes in the mitochondrial membrane potential, the determination of genotoxicity, and protein changes determined by capillary chromatography and tandem mass spectrometry with ESI were analyzed. The results showed that, in vitro, 5 Jcm−2 ZnPc PDT caused a significant increase in reactive oxygen species. Still, except for superoxide dismutase, the levels of proteins involved in cell response to oxidative stress did not increase significantly. Furthermore, this therapy damaged mitochondrial membranes, which was proven by a more than 70% voltage-dependent channel protein 1 level decrease and by a 65% mitochondrial membrane potential change 24 h post-therapy. DNA impairment was assessed by an increased level of DNA fragmentation, which might be related to the decreased level of DDB1 (decrease in levels of more than 20% 24 h post-therapy), a protein responsible for maintaining genomic integrity and triggering the DNA repair pathways. Considering these results and the low effective concentration (LC50 = 30 nM), the therapy used is a potentially very promising antitumoral treatment.

16 June 2023 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
MSMartin Snehota
Martin Snehota
MKMarketa Kolarikova
Marketa Kolarikova
JVJaromir Vachutka
Jaromir Vachutka
BHBarbora Hosikova
Barbora Hosikova
KBKlara Balazova
Klara Balazova
HKHana Kolarova
Hana Kolarova

1 July 2019 in Lékař a technika - Clinician and Technology
Verified
Journal Article
Open access
PDF file
BHBarbora Hosikova
Barbora Hosikova
SBSvatopluk Binder
Svatopluk Binder
RLRené Lenobel
René Lenobel
JMJakub Malohlava
Jakub Malohlava
JHJakub Hošík
Jakub Hošík
HKHana Kolářová
Hana Kolářová
This study deals with the utilization of photosensitizer (λmax ~ 660 nm) from the group of the phthalocyanines, in photodynamic therapy. Effect of the zinc phthalocyanine photosensitizer mediated photodynamic therapy was evaluated in vitro on the tumor cell line – HeLa (cervical cancer cells) using mass spectrometry and atomic force and fluorescent microscopy techniques.